Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MREO will decline by -1.00% over the next 2 Weeks and hit $0.39 by Monday, March 23, 2026. In that time frame, MREO's share price is expected to range between $0.36 and $0.42.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 23, 2026 | 0.36 | 0.39 | 0.42 |
| Mar 20, 2026 | 0.36 | 0.39 | 0.41 |
| Mar 19, 2026 | 0.36 | 0.38 | 0.41 |
| Mar 18, 2026 | 0.36 | 0.39 | 0.42 |
| Mar 17, 2026 | 0.37 | 0.39 | 0.42 |
| Mar 16, 2026 | 0.37 | 0.39 | 0.41 |
| Mar 13, 2026 | 0.37 | 0.39 | 0.41 |
| Mar 12, 2026 | 0.37 | 0.39 | 0.41 |
| Mar 11, 2026 | 0.37 | 0.39 | 0.42 |
| Mar 10, 2026 | 0.38 | 0.40 | 0.42 |
MREO shares rose +2.07% in Tuesday, March 10, 2026's trading session, rising from a previous close of $0.39 to move at $0.40. The stock demonstrated notable intraday movement (see MREO's key stats for a full breakdown), fluctuating between $0.39 and $0.41, a +5.21% trading range. While recent weeks have seen some volatility, MREO has managed to secure a -5.71% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 858.24K shares changing hands, 130.54K more than the previous session. This amounted to $343.04K in total market activity.
Will MREO Continue Its Upward Trend?
According to analyst ratings and projections for MREO, Mereo BioPharma Group plc shares are anticipated to increase by +4.75%, potentially reaching $0.42 per share by March 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for MREO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 8 positive trading days within the past 30 sessions. Based on the MREO stock forecast, now is a good time to buy MREO stock because its current trading price is +3.10% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MREO covering social and institutional perspectives.
MREO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MREO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.33% to 46.34%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 38.19%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 41.20%, maintains a neutral outlook for the long term. Insights into MREO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Mereo BioPharma Group Short-Term Forecasts
MREO Forecast For Next 5 Days
Our algorithm anticipates Mereo BioPharma Group (MREO) stock could hit $0.20 by Mar 17, 2026. This represents a -49.14% fall from today's price, following a -0.39% change over the past five days.
MREO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Mereo BioPharma Group plc (MREO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.14, which would mean a -64.97% decrease from the current price of $0.40. Projections for this period range from a high of $0.58 to a low of $0.00.
MREO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Mereo BioPharma Group's price over the next three months point to a rise. MREO stock is expected to peak at $2.09 on Mar 20, 2026 before potentially dipping to $0.80 on May 26, 2026. On average, MREO is likely to trade around $1.34 in the coming 90 days.
Mereo BioPharma Group Stock Forecast 2025
Based on our predictive models, Mereo BioPharma Group (MREO) is expected to trade between $0.00 and $2.09 throughout 2026. This would result in an average price of $1.05, potentially offering investors a +162.70% return from current levels.
Mereo BioPharma Group plc Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Mereo BioPharma Group plc (MREO) is positioned to show a strong performance in March 2026. The price is predicted to move between $1.39 and $2.09, settling at an average of $1.81. This could translate to a +352.84% gain.
April 2026
Based on current market signals, Mereo BioPharma Group plc is projected to trend april 2026. We forecast a trading range from $0.81 to $1.57, with a likely average price of $1.20. Investors could expect a potential return of +200.23%.
May 2026
Our predictive algorithms indicate Mereo BioPharma Group plc stock may see a shift in May 2026. The expected range spans $0.80–$1.68, with an average target of $1.19. This represents a positive outlook and a possible gain of +197.72%.
June 2026
Analyzing established trends, Mereo BioPharma Group plc looks set to move in June 2026. Projections place the stock between $0.80 and $1.46, averaging around $1.19. This suggests a +197.72% gain from current levels.
July 2026
Market indicators suggest Mereo BioPharma Group plc could experience notable changes during July 2026. Prices could fluctuate within $0.77 to $1.19, with a midpoint forecast of $1.02. The stock might deliver a +155.19% gain.
August 2026
Forecasting for August 2026, models estimate that Mereo BioPharma Group plc may undergo key fluctuations. If trends hold, the stock might trade between $0.68 and $1.27, averaging $1.09. This signals a positive trajectory with potential returns around +172.70%.
September 2026
According to our latest forecast models, Mereo BioPharma Group plc (MREO) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.54 and $1.18, settling at an average of $1.02. This could translate to a +155.19% gain.
October 2026
Based on current market signals, Mereo BioPharma Group plc is projected to trend october 2026. We forecast a trading range from $0.24 to $1.07, with a likely average price of $0.96. Investors could expect a potential return of +140.18%.
November 2026
Our predictive algorithms indicate Mereo BioPharma Group plc stock may see a shift in November 2026. The expected range spans $0.02–$0.76, with an average target of $0.68. This represents a positive outlook and a possible gain of +70.13%.
December 2026
Analyzing established trends, Mereo BioPharma Group plc looks set to move in December 2026. Projections place the stock between $0.00 and $0.45, averaging around $0.53. This suggests a +32.60% gain from current levels.
January 2027
Market indicators suggest Mereo BioPharma Group plc could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $0.29, with a midpoint forecast of $0.43. The stock might deliver a +7.58% gain.
February 2027
Forecasting for February 2027, models estimate that Mereo BioPharma Group plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.11, averaging $0.34. This signals a cautious trajectory with potential returns around -14.94%.
March 2027
According to our latest forecast models, Mereo BioPharma Group plc (MREO) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.02, settling at an average of $0.27. This could translate to a -32.45% loss.
MREO's history of dividends and stock splits also plays a role in long-term investor confidence.

